Developed for long-term lung support - approved for 29 days of use
Elementary features:
• Proven reliability and safety
• Certified for 29 days application period
• Matching pump sizes for ¼ "" or 3/8"" tubing
• x.ellence, a multi-layer coating for stable bio- and hemocompatible surfaces
• Fine adjustments of the flow rate possible
Available in three different sizes:
• iLA activve MiniLung petite kit
• iLA activve MiniLung kit
• iLA activve XLung kit"
For your information: Not all products are cleared or available for sale in all countries. For further information on country-specific regulations, please contact your local Xenios AG representative.
Also, this information is not intended for an audience within the USA. If your are from the USA, please visit the corresponding Fresenius Medical Care website here.
Specification:
o iLA activve MiniLung petite kit
o iLA activve MiniLung kit
o iLA activve iLA kit
o iLA activve XLung kit
Loading...
Advantech Connect Online Partner Conference to Promote Edge-to-Cloud Partnerships & AIoT Solutions
Advantech , a leading provider of advanced IoT intelligence systems,... Read more
Anticoagulation Therapy in Patients With COVID-19
No therapy is currently recommended for COVID-19. Some data from registries... Read more
FDA Recommends Against Reuse of Respirators
The U.S. Food and Drug Administration (FDA) has released new recommendati Read more
JOIN OUR MANAGEMENT COMMUNITY
Masimo Announces FDA Clearance of Radius PCG™ for Root® Patient Monitoring & Connectivity Platform
Masimo (NASDAQ: MASI) announced today that Radius PCG™, a portable real- Read more
Masimo to Present in 20th Annual Needham Healthcare Conference
Masimo (NASDAQ: MASI) today announced that its management is sche Read more
Study Investigates the Effects of Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients
Study Stresses the Importance of Brain Monitoring During the Treatment... Read more
New AMA President: Dr Susan Bailey
The 175th president of the American Medical Association (AMA),... Read more
Oliver Reichardt, RCR‘s New Chief Executive
As of May 4, Oliver Reichardt is new Chief Executive of t he... Read more
Dr. Sebastian Krolop appointed Chief Operating & Strategy Officer of HIMSS
Dr. Sebastian Krolop, M.D., Ph.D., M. Sc. has recently been appointed the... Read more
Dr. Paul Wischmeyer earns prestigious FASPEN award
The American Society for Parenteral and Enteral Nutrition (ASPEN) has... Read more
John Ormiston Awarded the EuroPCR 2017 Ethica Award
The 2017 Ethica Award, the highest honour of the European cardiovascular... Read more
Gamma Medica Bolsters Executive Team to Support Fight Against Breast Cancer
Gamma Medica, a leader in molecular breast imaging (MBI) technology, announced... Read more
JOIN OUR MANAGEMENT COMMUNITY
JOIN OUR MANAGEMENT COMMUNITY